Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients

Luigi Fontana, Filomena Addante, Massimiliano Copetti, Giulia Paroni, Andrea Fontana, Daniele Sancarlo, Fabio Pellegrini, Luigi Ferrucci, Alberto Pilotto

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

A combination of several metabolic and hormonal adaptations has been proposed to control aging. Little is known regarding the effects of multiple deregulations of these metabolic and hormonal systems in modulating frailty and mortality in hospitalized elderly patients. We measured 17 biological serum parameters from different metabolic/hormonal pathways in 594 hospitalized elderly patients followed up to 1 year who were stratified into three groups according to their multidimensional impairment, evaluated by a Comprehensive Geriatric Assessment (CGA)-based Multidimensional Prognostic Index (MPI). The mortality incidence rates were 7% at 1 month and 21% at 1 year. Our data show that frailty and mortality rate were positively associated with chronic inflammation and with a down-regulation of multiple endocrine factors. Of the 17 biomarkers examined, blood levels of IGF-1, triiodothyronine, C-reactive protein, erythrocyte sedimentation rate, white blood cell and lymphocyte counts, iron, albumin, total cholesterol, and LDL-c were significantly associated with both MPI severity grade and mortality. In multivariate Cox proportional hazard model, the following biomarkers most strongly predicted the risk of mortality (adjusted hazard ratio (HR) per 1 quintile increment in predictor distribution): IGF-1 HR = 0.71 (95% CI: 0.63-0.80), CRP HR = 1.48 (95% CI: 1.32-1.65), hemoglobin HR = 0.82 (95% CI: 0.73-0.92), and glucose HR = 1.17 (95% CI: 1.04-1.30). Multidimensional impairment assessed by MPI is associated with a distinctive metabolic 'signature'. The concomitant elevation of markers of inflammation, associated with a simultaneous reduction in multiple metabolic and hormonal factors, predicts mortality in hospitalized elderly patients.

Original languageEnglish
Pages (from-to)459-466
Number of pages8
JournalAging Cell
Volume12
Issue number3
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Mortality
Insulin-Like Growth Factor I
Biomarkers
Inflammation
Geriatric Assessment
Blood Sedimentation
Lymphocyte Count
Triiodothyronine
Metabolic Networks and Pathways
Leukocyte Count
Proportional Hazards Models
C-Reactive Protein
LDL Cholesterol
Albumins
Hemoglobins
Down-Regulation
Iron
Glucose
Incidence
Serum

Keywords

  • Comprehensive geriatric assessment
  • IGF-1
  • Inflammation
  • Mortality
  • Multidimensional prognostic index
  • Testosterone

ASJC Scopus subject areas

  • Cell Biology
  • Ageing

Cite this

Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients. / Fontana, Luigi; Addante, Filomena; Copetti, Massimiliano; Paroni, Giulia; Fontana, Andrea; Sancarlo, Daniele; Pellegrini, Fabio; Ferrucci, Luigi; Pilotto, Alberto.

In: Aging Cell, Vol. 12, No. 3, 06.2013, p. 459-466.

Research output: Contribution to journalArticle

Fontana, Luigi ; Addante, Filomena ; Copetti, Massimiliano ; Paroni, Giulia ; Fontana, Andrea ; Sancarlo, Daniele ; Pellegrini, Fabio ; Ferrucci, Luigi ; Pilotto, Alberto. / Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients. In: Aging Cell. 2013 ; Vol. 12, No. 3. pp. 459-466.
@article{0d1769e3ade84ea49ee95fd75abe4b2e,
title = "Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients",
abstract = "A combination of several metabolic and hormonal adaptations has been proposed to control aging. Little is known regarding the effects of multiple deregulations of these metabolic and hormonal systems in modulating frailty and mortality in hospitalized elderly patients. We measured 17 biological serum parameters from different metabolic/hormonal pathways in 594 hospitalized elderly patients followed up to 1 year who were stratified into three groups according to their multidimensional impairment, evaluated by a Comprehensive Geriatric Assessment (CGA)-based Multidimensional Prognostic Index (MPI). The mortality incidence rates were 7{\%} at 1 month and 21{\%} at 1 year. Our data show that frailty and mortality rate were positively associated with chronic inflammation and with a down-regulation of multiple endocrine factors. Of the 17 biomarkers examined, blood levels of IGF-1, triiodothyronine, C-reactive protein, erythrocyte sedimentation rate, white blood cell and lymphocyte counts, iron, albumin, total cholesterol, and LDL-c were significantly associated with both MPI severity grade and mortality. In multivariate Cox proportional hazard model, the following biomarkers most strongly predicted the risk of mortality (adjusted hazard ratio (HR) per 1 quintile increment in predictor distribution): IGF-1 HR = 0.71 (95{\%} CI: 0.63-0.80), CRP HR = 1.48 (95{\%} CI: 1.32-1.65), hemoglobin HR = 0.82 (95{\%} CI: 0.73-0.92), and glucose HR = 1.17 (95{\%} CI: 1.04-1.30). Multidimensional impairment assessed by MPI is associated with a distinctive metabolic 'signature'. The concomitant elevation of markers of inflammation, associated with a simultaneous reduction in multiple metabolic and hormonal factors, predicts mortality in hospitalized elderly patients.",
keywords = "Comprehensive geriatric assessment, IGF-1, Inflammation, Mortality, Multidimensional prognostic index, Testosterone",
author = "Luigi Fontana and Filomena Addante and Massimiliano Copetti and Giulia Paroni and Andrea Fontana and Daniele Sancarlo and Fabio Pellegrini and Luigi Ferrucci and Alberto Pilotto",
year = "2013",
month = "6",
doi = "10.1111/acel.12068",
language = "English",
volume = "12",
pages = "459--466",
journal = "Aging Cell",
issn = "1474-9718",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients

AU - Fontana, Luigi

AU - Addante, Filomena

AU - Copetti, Massimiliano

AU - Paroni, Giulia

AU - Fontana, Andrea

AU - Sancarlo, Daniele

AU - Pellegrini, Fabio

AU - Ferrucci, Luigi

AU - Pilotto, Alberto

PY - 2013/6

Y1 - 2013/6

N2 - A combination of several metabolic and hormonal adaptations has been proposed to control aging. Little is known regarding the effects of multiple deregulations of these metabolic and hormonal systems in modulating frailty and mortality in hospitalized elderly patients. We measured 17 biological serum parameters from different metabolic/hormonal pathways in 594 hospitalized elderly patients followed up to 1 year who were stratified into three groups according to their multidimensional impairment, evaluated by a Comprehensive Geriatric Assessment (CGA)-based Multidimensional Prognostic Index (MPI). The mortality incidence rates were 7% at 1 month and 21% at 1 year. Our data show that frailty and mortality rate were positively associated with chronic inflammation and with a down-regulation of multiple endocrine factors. Of the 17 biomarkers examined, blood levels of IGF-1, triiodothyronine, C-reactive protein, erythrocyte sedimentation rate, white blood cell and lymphocyte counts, iron, albumin, total cholesterol, and LDL-c were significantly associated with both MPI severity grade and mortality. In multivariate Cox proportional hazard model, the following biomarkers most strongly predicted the risk of mortality (adjusted hazard ratio (HR) per 1 quintile increment in predictor distribution): IGF-1 HR = 0.71 (95% CI: 0.63-0.80), CRP HR = 1.48 (95% CI: 1.32-1.65), hemoglobin HR = 0.82 (95% CI: 0.73-0.92), and glucose HR = 1.17 (95% CI: 1.04-1.30). Multidimensional impairment assessed by MPI is associated with a distinctive metabolic 'signature'. The concomitant elevation of markers of inflammation, associated with a simultaneous reduction in multiple metabolic and hormonal factors, predicts mortality in hospitalized elderly patients.

AB - A combination of several metabolic and hormonal adaptations has been proposed to control aging. Little is known regarding the effects of multiple deregulations of these metabolic and hormonal systems in modulating frailty and mortality in hospitalized elderly patients. We measured 17 biological serum parameters from different metabolic/hormonal pathways in 594 hospitalized elderly patients followed up to 1 year who were stratified into three groups according to their multidimensional impairment, evaluated by a Comprehensive Geriatric Assessment (CGA)-based Multidimensional Prognostic Index (MPI). The mortality incidence rates were 7% at 1 month and 21% at 1 year. Our data show that frailty and mortality rate were positively associated with chronic inflammation and with a down-regulation of multiple endocrine factors. Of the 17 biomarkers examined, blood levels of IGF-1, triiodothyronine, C-reactive protein, erythrocyte sedimentation rate, white blood cell and lymphocyte counts, iron, albumin, total cholesterol, and LDL-c were significantly associated with both MPI severity grade and mortality. In multivariate Cox proportional hazard model, the following biomarkers most strongly predicted the risk of mortality (adjusted hazard ratio (HR) per 1 quintile increment in predictor distribution): IGF-1 HR = 0.71 (95% CI: 0.63-0.80), CRP HR = 1.48 (95% CI: 1.32-1.65), hemoglobin HR = 0.82 (95% CI: 0.73-0.92), and glucose HR = 1.17 (95% CI: 1.04-1.30). Multidimensional impairment assessed by MPI is associated with a distinctive metabolic 'signature'. The concomitant elevation of markers of inflammation, associated with a simultaneous reduction in multiple metabolic and hormonal factors, predicts mortality in hospitalized elderly patients.

KW - Comprehensive geriatric assessment

KW - IGF-1

KW - Inflammation

KW - Mortality

KW - Multidimensional prognostic index

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=84877832333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877832333&partnerID=8YFLogxK

U2 - 10.1111/acel.12068

DO - 10.1111/acel.12068

M3 - Article

C2 - 23496093

AN - SCOPUS:84877832333

VL - 12

SP - 459

EP - 466

JO - Aging Cell

JF - Aging Cell

SN - 1474-9718

IS - 3

ER -